“Hepatitis b”的搜索结果，显示 391-400 项，共有 10582 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

4. 乳腺癌 - 医生与科室 - 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

5. 血液科- 临床试验- 妙佑医疗国际

   ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

6. 弥漫性大B 细胞淋巴瘤- 医生与科室- 妙佑医疗国际

   Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL). Jacksonville ...

8. Periprosthetic joint infection (PJI)

   To diagnose a periprosthetic joint infection (PJI), your healthcare team may use a combination of a physical exam, lab tests, imaging tests and joint fluid ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...